EffRx Exhibiting at the Austrian-Swiss Metabolic Meeting in Zürich on the 7th and 8th of April 2022

EffRx is having a booth at the ASMM 2022 Meeting which focuses on “New technologies, new treatments and new challenges.” EffRx will present two products, the Swiss-marketed Miglustat and soon-to-be-launched Alkindi.